Agilon Health, Inc. (NYSE:AGL) Receives $50.20 Consensus Target Price from Analysts

Shares of Agilon Health, Inc. (NYSE:AGL) have been given an average rating of “Hold” by the fifteen ratings firms that are covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, ten have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $40.2250.

AGL has been the topic of several analyst reports. Deutsche Bank Aktiengesellschaft set a $33.00 price objective on Agilon Health and gave the stock a “hold” rating in a report on Thursday, April 9th. Benchmark lifted their price objective on Agilon Health to $13.00 and gave the stock a “buy” rating in a report on Thursday, April 2nd. Barclays dropped their price objective on Agilon Health from $25.00 to $12.50 and set an “underweight” rating on the stock in a report on Friday, February 27th. Weiss Ratings restated a “sell (e+)” rating on shares of Agilon Health in a report on Wednesday, January 21st. Finally, Wells Fargo & Company lifted their price objective on Agilon Health from $25.00 to $37.50 and gave the stock an “overweight” rating in a report on Friday, February 27th.

Institutional Investors Weigh In On Agilon Health

Several hedge funds and other institutional investors have recently bought and sold shares of the business. North Peak Capital Management LLC increased its holdings in shares of Agilon Health by 10.8% in the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after acquiring an additional 3,715,460 shares during the last quarter. Goldman Sachs Group Inc. increased its holdings in shares of Agilon Health by 196.2% in the 4th quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after acquiring an additional 13,283,930 shares during the last quarter. CenterBook Partners LP increased its holdings in shares of Agilon Health by 492.4% in the 3rd quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock valued at $11,771,000 after acquiring an additional 9,499,012 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of Agilon Health by 1,346.6% in the 4th quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock valued at $7,033,000 after acquiring an additional 9,505,837 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Agilon Health by 30.9% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 8,019,002 shares of the company’s stock valued at $5,523,000 after acquiring an additional 1,893,434 shares during the last quarter.

Agilon Health Stock Up 6.1%

Agilon Health stock traded up $1.74 during midday trading on Tuesday, hitting $30.04. 37,095 shares of the company were exchanged, compared to its average volume of 298,090. The company’s fifty day moving average price is $14.41 and its 200-day moving average price is $17.88. The company has a market cap of $498.35 million, a PE ratio of -1.26 and a beta of 0.33. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. Agilon Health has a fifty-two week low of $7.48 and a fifty-two week high of $119.50.

Agilon Health (NYSE:AGL) last released its quarterly earnings results on Wednesday, February 25th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.27) by ($0.19). Agilon Health had a negative return on equity of 120.82% and a negative net margin of 6.60%.The company had revenue of $1.57 billion for the quarter, compared to analyst estimates of $1.46 billion. On average, research analysts predict that Agilon Health will post -6.35 EPS for the current fiscal year.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.